Safety, Efficacy and Immunogenicity of Chadox1 Ncov-19 Vaccine: Rapid Systematic Review and Meta Analysis
试验速览
- 阶段
- 不适用
- 入组人数
- 2,000
- 试验地点
- 1
- 主要终点
- To evaluate the safety and efficacy of the ChAdOx1 nCoV-19 vaccine in a pooled interim analysis
研究概览
简要总结
Since the beginning of COVID-19 pandemic, a safe and effective vaccine against infection and development of acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is needed control of the wide spread of COVID-19 and reduce death rates throughout the world. Many clinical trials investigated the immunogenicity of different proposed vaccine including the first distributed vaccine; the ChAdOx1 nCoV-19 vaccine and there is a need to analyze the results of published clinical trials.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Other
入排标准
- 年龄范围
- 18 Years 至 80 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Participant who received 2 doses of ChAdOx1 nCoV-19 vaccine
排除标准
- •non vaccinated person
结局指标
主要结局
To evaluate the safety and efficacy of the ChAdOx1 nCoV-19 vaccine in a pooled interim analysis
时间窗: up to one year
the frequency of breakthrough COVID-19 infection
次要结局
未报告次要终点
研究者
Aliae AR Mohamed Hussein
Professor of Pulmonology
Assiut University
